Earnings History Data for Edesa Biotech, Inc. (EDSA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Edesa Biotech, Inc.
Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage. Edesa Biotech Inc., formerly known as Stellar Biotechnologies Inc., is based in TORONTO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-08-2023 | AH | EDSA | Edesa Biotech | 19.00 | -0.10 | -0.17 | 0.00 | Edesa Biotech GAAP EPS of -$0.10 beats by $0.07 [8/9/2023 5:35 PM] |
0.8781 | -0.04 (-4.24%) |
0.93 | 0.01 (1.42%) |
0.76 - 2.81 | 62,714 | 50,000 | 2,533 | ||
| 11-05-2023 | AH | EDSA | Edesa Biotech, Inc. | 19.85 | -0.12 | -0.17 | -0.33 | Edesa Biotech GAAP EPS of -$0.12 beats by $0.05 [5/11/2023 5:30 PM] |
0.90 | -0.05 (-4.77%) |
0.0 | 0.0 (0.00%) |
0.76 - 2.81 | 80,965 | 90,000 | 0 | ||
| 10-02-2023 | PM | EDSA | Edesa Biotech, Inc. | 27.68 | -0.13 | -0.19 | -0.33 | Edesa Biotech GAAP EPS of -$0.13 beats by $0.06 [2/10/2023 9:38 AM] |
1.39 | -0.05 (-3.47%) |
1.44 | 0.0 (0.00%) |
0.76 - 4.10 | 62,393 | 120,000 | 107 | ||
|
|
||||||||||||||||||
| 13-08-2021 | PM | EDSA | Edesa Biotech, Inc. | 60.00 | -0.36 | -0.32 | 0.00 | Edesa Biotech EPS misses by $0.04 [8/13/2021 8:02 AM] |
4.53 | -0.02 (-0.44%) |
0.0 | 0.0 (0.00%) |
4.05 - 10.15 | 30,908 | 40,000 | 0 | ||
| 14-05-2021 | PM | EDSA | Edesa Biotech, Inc. | 81.00 | -0.19 | -0.30 | 0.00 | Edesa Biotech EPS beats by $0.10 [5/14/2021 8:49 AM] |
5.98 | 0.11 (1.87%) |
0.0 | 0.0 (0.00%) |
2.46 - 19.10 | 107,701 | 400,000 | 0 | ||
| 16-02-2021 | PM | EDSA | Edesa Biotech, Inc. | 75.00 | -0.26 | -0.19 | 0.00 | 6.98 | -0.14 (-1.97%) |
7.15 | 0.03 (0.42%) |
1.58 - 19.10 | 241,348 | 643,246 | 5,610 | |||
|
|
||||||||||||||||||
| 16-02-2021 | ?? | EDSA | Edesa Biotech, Inc. | 74.92 | -0.26 | -0.19 | -0.15 | Edesa Biotech EPS beats by $0.02 [2/17/2021 5:32 AM] |
7.25 | 0.18 (2.55%) |
7.03 | -0.04 (-0.57%) |
1.58 - 19.10 | 161,684 | 513,465 | 797 | ||
| 07-12-2020 | PM | EDSA | Edesa Biotech, Inc. | 47.00 | -0.22 | -0.21 | 0.00 | Edesa Biotech EPS misses by $0.04, beats on revenue [12/7/2020 8:09 AM] |
4.75 | -0.15 (-3.06%) |
5.00 | 0.10 (2.04%) |
1.58 - 19.10 | 65,479 | 84,081 | 259 | ||
| 12-08-2020 | PM | EDSA | Edesa Biotech, Inc. | 74.15 | -0.20 | -0.21 | -0.30 | Edesa Biotech EPS misses by $0.02, beats on revenue [8/12/2020 7:48 AM] |
7.10 | 0.29 (4.31%) |
7.20 | 0.39 (5.73%) |
1.58 - 19.10 | 93,536 | 5,187,814 | 2,601 | ||
|
|
||||||||||||||||||